MALIGNANT TUMORS ARISING DE NOVO IN IMMUNOSUPPRESSED ORGAN TRANSPLANT RECIPIENTS
- 1 October 1972
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 14 (4), 407-417
- https://doi.org/10.1097/00007890-197210000-00001
Abstract
De novo malignant tumors have been observed throughout the world in 75 chronic survivors of organ transplantation, including 16 of our own patients. The incidence of tumors was approximately 80 times greater than in the average population in a comparable age range. Chronic uremia may have predisposed to the development of some of the tumors, but this has not yet been proved. It seems clear that the predominant etiology was chronic immunosuppression post-transplantation. Forty-four of the patients had epithelial tumors and in 31 the lesions were of mesenchymal origin. On the average the malignancies appeared 29 months after transplantation. Lymphomas showed an unusual-predilection for involvement of the central nervous system. Carcinomas of the skin, lip, and uterine cervix were successfully treated by conventional techniques. On the other hand, carcinomas of the thoracic or abdominal organs and mesenchymal tumors led or contributed to early death in most cases. For this reason drastic reduction or even discontinuance of immunosuppression should be considered in the management of these latter tumors. Copyright © 1972 Wolters Kluwer Health, Inc. All rights reserved.Keywords
This publication has 20 references indexed in Scilit:
- National Registry of Long-Term Dialysis PatientsJama-Journal Of The American Medical Association, 1971
- Iatrogenic Alterations of Immunologic Surveillance in Man and Their Influence on MalignancyImmunological Reviews, 1971
- Cerebral Neoplasms Associated With Renal TransplantationArchives of Neurology, 1970
- The Concept of Immunological SurveillancePublished by S. Karger AG ,1969
- Malignant lymphomas in transplantation patients.1969
- Five Yearsʼ Experience in Renal Transplantation with Immunosuppressive DrugsAnnals of Surgery, 1968
- Malignant Lymphoproliferative Diseases: Interactions Between Immunological Abnormalities and Oncogenic VirusesAnnual Review of Medicine, 1968
- Renal lesions associated with malignant lymphomasAmerican Journal Of Medicine, 1962
- Cancer--A Biological Approach: I. The Processes Of Control. II. The Significance of Somatic MutationBMJ, 1957
- PROLONGED SURVIVAL OF SKIN HOMOGRAFTS IN UREMIC PATIENTSAnnals of the New York Academy of Sciences, 1957